3 unknown, 2 completed, 1 not yet recruiting. 4 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 3, Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Megalabs: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients Experimental: Epoetin alfa Megalabs® Erythropoietin injectable in intravenous administration., Active comparator: European Union licenced epoetin alfa - Anemia of Chronic Kidney Disease | Phase 3 | Not yet recruiting | Megalabs | 280 | 2025-07-01 | 2024-08-19 |
| Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers Filgrastim Megalabs, Granulokine - Healthy | Phase 1 | Unknown | Megalabs | 100 | 2024-11-01 | 2024-08-16 |
| Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU, Active comparator Erythropoietin subcutaneous injection single dose of 4,000 IU - Healthy | Phase 1 | Unknown | Megalabs | 52 | 2024-10-06 | 2024-08-21 |
| A Pilot Bioequivalence Study of Pomalidomide Pomalidomide 4 MG Oral Capsule - Bioequivalence Study | Phase 1 | Unknown | Megalabs | 10 | 2024-09-15 | 2023-09-28 |
| Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg Palbociclib 125mg - Bioequivalence | Phase 4 | Completed | Megalabs | 24 | 2024-02-06 | 2024-08-19 |
| Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers Pegfilgastrim Megalabs, Pegfilgastim Amgen - Neutropenia | Phase 1 | Completed | Megalabs | 72 | 2022-03-18 | 2024-08-16 |
Neutropenia (1)
Administration, Intravenous (1) · Epoetin Alfa (1) · palbociclib (1) · pomalidomide (1)
India (3) · Uruguay (2)
Satish Kumar, MD (3) · M Gowtham, MD (1) · M. Gowtham, MD (1)